Skip to main content

Articles

Page 6 of 11

  1. Two billion people worldwide, predominantly in low- and middle-income countries, cannot consistently access required essential medications, thus affecting their ability to attain optimal health outcomes. Acces...

    Authors: Marcia McLean, Jillian Clare Kohler and Danny Edwards
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:26
    Content type: Research Published on:

  2. To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.

    Authors: Alberto Frutos Pérez-Surio, Mercedes Gimeno-Gracia, Ma. Aránzazu Alcácera López, Ma. Asunción Sagredo Samanes, Ma. del Puerto Pardo Jario and Ma. del Tránsito Salvador Gómez
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:21
    Content type: Short report Published on:

  3. To describe changes in the private market for selected originators, branded generics (‘similares’), and generic products during the 10 years following passage of the Brazilian Generics Law.

    Authors: Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:18
    Content type: Research Published on:

  4. Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulati...

    Authors: Bethany Wilson, Sara S. McMillan and Amanda J. Wheeler
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:19
    Content type: Research Published on:

  6. The rational use of medicine improves patient’s quality of life. Excessive and inappropriate prescriptions result in severe consequences. The study of drug use patterns and prescription errors is necessary to ...

    Authors: Rajeev Shrestha and Srijana Prajapati
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:16
    Content type: Research Published on:

  7. As part of the initiatives to increase price transparency for consumers, pharmaceutical industry in Malaysia have been encouraged to declare the wholesale and recommended retail prices (RRP) of medicines to th...

    Authors: Nur Sufiza Ahmad, Ernieda Hatah and Mohd Makmor-Bakry
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:15
    Content type: Research Published on:

  8. Pharmaceutical pricing has only recently gained space in mainstream health science literature.

    Authors: Maria Angelica Borges dos Santos, Leticia Lucia dos Santos Dias, Cláudia Du Bocage Santos Pinto, Rondineli Mendes da Silva and Claudia Garcia Serpa Osorio-de-Castro
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:24
    Content type: Review Published on:

  9. Methemoglobinemia (MetHb) being a rare cause of cyanosis is generally not considered in its differential diagnosis. Methemoglobinemia is an abnormal Hb produced physiologically by auto-oxidation. If this proce...

    Authors: Najia Mahmood, Mutti Ullah Khan, Ihtisham U. L. Haq, Farhat Afshan Jelani and Aayesha Tariq
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:22
    Content type: Short report Published on:

  10. Questionnaires capture patient perspectives succinctly and at relatively low cost, making them a popular data collection tool for health researchers. However, questionnaire data can be affected by response err...

    Authors: Marissa Ayano Mes, Amy Hai Yan Chan, Vari Wileman, Caroline Brigitte Katzer, Melissa Goodbourn, Steven Towndrow, Stephanie Jane Caroline Taylor and Rob Horne
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:17
    Content type: Commentary Published on:

  11. Few low and middle-income countries (LMIC) have fully operational pharmacovigilance structures, systems and legal framework to collect and collate safety data and evaluate the risks and benefits by active and ...

    Authors: Onome T. Abiri and Wiltshire C. N. Johnson
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:13
    Content type: Research Published on:

  12. Improving access to medicines is a major healthcare challenge for low-income countries because the problem traverses health systems, society and multiple stakeholders. The Annapurna region of Nepal provides a ...

    Authors: Bhuvan K.C., Susan Heydon and Pauline Norris
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:11
    Content type: Research Published on:

  13. Countries all around the globe are working to establish robust pharmacovigilance systems. Whereas the majority of the developed countries have established well-organized pharmacovigilance systems, the developi...

    Authors: Rabia Hussain and Mohamed Azmi Hassali
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:14
    Content type: Commentary Published on:

  14. Existing literature does not provide enough information on evaluation of factors associated with pre-dialysis controlled hypertension among euvolemic hemodialysis (HD) patients. We conducted a study to evaluat...

    Authors: Amjad Khan, Amer Hayat Khan, Azreen Syazril Adnan, Syed Azhar Syed Sulaiman, Saima Mushtaq, Nafees Ahmad and Irfanullah Khan
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:10
    Content type: Research Published on:

  15. Universal Health Coverage (UHC) in Indonesia is planned to be fully implemented in 2019 through the National Health Insurance (NHI) launched in January 2014. However, limited financial resources cause health c...

    Authors: Endang Yuniarti, Yayi Suryo Prabandari, Erna Kristin and Sri Suryawati
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:7
    Content type: Research Published on:

  16. Expired or unused medicines are potentially toxic substances that should be managed effectively to avoid accumulation of potentially toxic pharmaceuticals in the environment. In Nigeria, there is currently lim...

    Authors: Iweh Michael, Brian Ogbonna, Nduka Sunday, Maureen Anetoh and Okonta Matthew
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:12
    Content type: Research Published on:

  17. In Kuwait, the government is planning to improve the specifications for purchase of medicine and to improve the tendering system intending to slow the growth of the expenditure for medicine and to improve the ...

    Authors: Ali Hadi Abdullah, Anke-Peggy Holtorf, Maryam Al-Hussaini, Jacinthe Lemay, Maryam Alowayesh and Zoltán Kaló
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:9
    Content type: Research Published on:

  18. Urinary tract infections (UTI) are commonly encountered in the emergency department (ED). ED culture follow up is an important tool to provide the appropriate therapy after the identification of the causative ...

    Authors: Abdulaziz Saleh Almulhim, Ali Aldayyen, Kateryna Yenina, Adam Chiappini and Tahir Mehmood Khan
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:8
    Content type: Research Published on:

  19. Proton pump inhibitors (PPIs) are used worldwide for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). Although considered to be widely safe, PPIs have been associated wit...

    Authors: Ejaz Cheema
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:6
    Content type: Review Published on:

  20. Pharmacy-based interventions are complex public health endeavors which include, but are not restricted to, the conventional medication supply role. In diabetes, such interventions may improve patients’ outcome...

    Authors: Suzete Costa, Maria Rute Horta, Rita Santos, Zilda Mendes, Isabel Jacinto, José Guerreiro, Maria Cary, Ana Miranda, Dennis K. Helling and Ana Paula Martins
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:5
    Content type: Review Published on:

  21. The availability of medicines in public health facilities in Tanzania is problematic. Medicines shortages are often caused by unavailability at Medical Stores Department, the national supplier for public healt...

    Authors: Karin Wiedenmayer, Romuald Mbwasi, William Mfuko, Ezekiel Mpuya, James Charles, Fiona Chilunda, Denis Mbepera and Ntuli Kapologwe
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:4
    Content type: Research Published on:

  22. Self-medication is a common practice globally and the resulting irrational drug use is raising concerns. Up-to-date there is no systematic study conducted on self medication practice among students or the gene...

    Authors: Zenawi Zeramariam Araia, Nahom Kiros Gebregziabher and Araia Berhane Mesfun
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:3
    Content type: Research Published on:

  23. The National Drug Authority (NDA) inspects and certifies private and public sector pharmacies in Uganda using an indicator-based inspection tool that measures adherence to good pharmacy practices (GPP). 67 mea...

    Authors: Brian Sekayombya, David Nahamya, Laura Garabedian, Morries Seru and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:2
    Content type: Research Published on:

  24. To stimulate use of generic medicines a combination of supply and demand side mechanisms are employed in the Latvian reimbursement system. It is reported that patients have high out-of-pocket pharmaceutical sp...

    Authors: Ieva Salmane Kulikovska, Elita Poplavska, Marija Ceha and Signe Mezinska
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:1
    Content type: Research Published on:

  25. In Ghana, there is extensive over-the-counter dispensing of antibiotics, resulting in high levels of inappropriate use, and an increase in antibiotic resistance. Regulations prevent Licenced Chemical Sellers (...

    Authors: Samuel Afari-Asiedu, John Kinsman, Ellen Boamah-Kaali, Martha Ali Abdulai, Margaret Gyapong, Osman Sankoh, Marlies Hulscher, Kwaku Poku Asante and Heiman Wertheim
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:30
    Content type: Research Published on:

  26. High medicines prices increasingly pose challenges for universal access to treatments of communicable and non-communicable diseases. New essential medicines are often patent-protected which sustains high price...

    Authors: Ellen F. M. ‘t Hoen, Tapiwanashe Kujinga and Pascale Boulet
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:31
    Content type: Review Published on:

  27. In the United States (U.S.), large price increases for selected generic drugs have elicited public outrage. Recent legislative proposals aim to increase price transparency and identify outlier drug “price spik...

    Authors: Rena M. Conti, Kevin H. Nguyen and Meredith B. Rosenthal
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:29
    Content type: Research Published on:

  28. Pharmaceuticals are produced and consumed in increasing volume every year. Unfortunately, not all medications that go in to the hand of the consumers get consumed; large quantities remain unused or expire. The...

    Authors: Yohanes Ayele and Mulu Mamu
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:27
    Content type: Research Published on:

  29. Canadians have long been proud of their universal health insurance system, which publicly funds the cost of physician visits and hospitalizations at the point of care. Prescription drugs however, have been sub...

    Authors: Jaden Brandt, Brenna Shearer and Steven G. Morgan
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:28
    Content type: Review Published on:

  30. Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin Americ...

    Authors: Daniela Moye-Holz, Rene Soria Saucedo, Jitse P van Dijk, Sijmen A Reijneveld and Hans V Hogerzeil
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:25
    Content type: Research Published on:

  31. Rational prescribing remains an important component of rational drug use. The World Health Organization (WHO) standardized and validated core prescribing indicators for evaluating prescribing pattern of drugs....

    Authors: Tigist Gashaw, Mekonnen Sisay, Getnet Mengistu and Firehiwot Amare
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:26
    Content type: Research Published on:

  32. A strong pharmaceutical sector is a precondition for effective and efficient health care and financing systems, and thus for achieving the best possible health of a population. Supported by visionary, long-ter...

    Authors: Martin Oteba, Anita Katharina Wagner, Morries Seru, Martha Embrey and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:23
    Content type: Commentary Published on:

  33. The United States-Peru Free Trade Agreement required changes in the Peruvian pharmaceutical legislation that resulted in the National Drug Policy (NDP) of 2009. This study evaluated the registration of brand a...

    Authors: Lita Araujo and Michael Montagne
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:24
    Content type: Research Published on:

  34. The emergency response phase to HIV epidemic in Nigeria and other countries saw to the deployment of donors’ resources with little consideration for country ownership (CO) and sustainability. The progress that...

    Authors: Ademola Joshua Itiola and Kenneth Anene Agu
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:21
    Content type: Research Published on:

  35. Pharmacists are critical for attaining the goal of universal health coverage and equitable access to essential health services, particularly in relation to access to medicines and medicines expertise. We descr...

    Authors: Aniekan Ekpenyong, Arit Udoh, Eneyi Kpokiri and Ian Bates
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:20
    Content type: Research Published on:

  36. In Australia, community pharmacists are increasingly being integrated into the healthcare system. A range of services in pharmacies are government-funded aiming to prevent chronic diseases and improve the qual...

    Authors: Vera H. Buss, Alison Shield, Sam Kosari and Mark Naunton
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:22
    Content type: Review Published on:

  37. Obesity is now widely regarded as a main contributor to poor health. Involvement of community pharmacists can be a valuable tool in obesity management. However, there is still a lack of data in Malaysia on the...

    Authors: Rohit Kumar Verma, Thomas Paraidathathu, Nur Akmar Taha and Wei Wen Chong
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:17
    Content type: Research Published on:

  38. The cost and potential harms of medicines and other health technologies are issues of concern for governments and third party payers of health care. Various means have been demonstrated to promote appropriate ...

    Authors: Lynn Maria Weekes, Suzanne Blogg, Sharene Jackson and Kerren Hosking
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:19
    Content type: Commentary Published on:

  39. Medication safety is a major public health concern and there are well established pharmacovigilance programmes in developed countries. However, there is scarcity of literature on the issue in low and middle in...

    Authors: Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi and Maryam Farooqui
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:16
    Content type: Research Published on:

  41. In late 2010, Uganda introduced a supervision, performance assessment, and recognition strategy (SPARS) to improve staff capacity in medicines management in government and private not-for-profit health facilit...

    Authors: Birna Trap, Richard Musoke, Anthony Kirunda, Martin Olowo Oteba, Martha Embrey and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:15
    Content type: Research Published on:

  42. The regulatory requirements for approval of generic medicines and the format of compiling drug dossiers vary among regulatory authorities. The variation is particularly wide between High-income countries (HIC)...

    Authors: D. Thambavita, P. Galappatthy and R. L. Jayakody
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:14
    Content type: Research Published on:

  43. Appropriate labeling of marketed medicines is necessary to fulfill the regulatory provisions and ensure patient medication safety. This study aimed to assess the primary labeling of medicines manufactured and ...

    Authors: Ramesh Sharma Poudel, Shakti Shrestha, Santosh Thapa, Bhupendra Kumar Poudel and Muniraj Chhetri
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:13
    Content type: Research Published on:

  44. Few guidelines exist on safe prescription of postoperative analgesia to obese patients undergoing ambulatory surgery. This study examines the preferences of providers in the standard treatment of postoperative...

    Authors: Anthony H. Bui, David L. Feldman, Michael L. Brodman, Peter Shamamian, Ronald N. Kaleya, Meg A. Rosenblatt, Debra D’Angelo, Donna Somerville, Santosh Mudiraj, Patricia Kischak and I. Michael Leitman
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:9
    Content type: Research Published on:

  45. To build capacity in medicines management, the Uganda Ministry of Health introduced a nationwide supervision, performance assessment and recognition strategy (SPARS) in 2012. Medicines management supervisors (...

    Authors: Belinda Blick, Stella Nakabugo, Laura F. Garabedian, Morries Seru and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:11
    Content type: Research Published on:

  46. Today, a combination of globalization of pharmaceutical production, lack of regulatory harmonization, and weakness of Medicines Regulatory Authorities, creates the “perfect conditions” for poor-quality medicin...

    Authors: Raffaella Ravinetto, Tim Roosen and Catherine Dujardin
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:12
    Content type: Commentary Published on:

  47. The biennial Commonwealth Heads of Government Meeting (CHOGM) this year is based around four key themes: prosperity, fairness, sustainability and security. This is an opportune time to consider the role of pha...

    Authors: Victoria Rutter, Amy Hai Yan Chan, Chloe Tuck, Lina Bader, Zaheer-Ud-Din Babar and Ian Bates
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:10
    Content type: Editorial Published on:

  48. Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new ince...

    Authors: Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi and John-Arne Røttingen
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:8
    Content type: Research Published on:

  49. In order to engage pharmacies in tuberculosis (TB) care, a survey was conducted in the Dera Ismail (DI) Khan City of the Khyber Pakhtoon Khwa province, Pakistan. The objectives were to; 1) characterize the ret...

    Authors: Tehmina Mustafa, Yasir Shahzad and Ayyaz Kiani
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:7
    Content type: Research Published on:

  50. Biosimilars could be a promising option to help decrease healthcare costs and expand access to treatment. There is no previous evidence of a global bibliometric analysis on biosimilars. Therefore, we aimed to ...

    Authors: Akram Hernández-Vásquez, Christoper A. Alarcon-Ruiz, Guido Bendezu-Quispe, Daniel Comandé and Diego Rosselli
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:6
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us